罗欣药业：2025年第三季度归属于上市公司股东的净利润同比增长102.96%

Core Insights - The company reported a revenue of 646,173,009.72 yuan for the third quarter of 2025, representing a year-on-year growth of 3.94% [1] - The net profit attributable to shareholders of the listed company was 5,231,766.19 yuan, showing a significant year-on-year increase of 102.96% [1]